StonvexLoading…
StonvexStonvexStonvexCore line items from NI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $6.52B | $5.28B | $5.35B | $5.74B |
Operating Income | $1.84B | $1.46B | $1.30B | $1.27B |
Net Income | $929.50M | $760.40M | $714.30M | $804.10M |
EPS (Diluted) | $1.95 | $1.62 | $1.48 | $1.70 |
Total Assets | $35.86B | $31.79B | $31.08B | $26.74B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $110.10M | $156.60M | $2.25B | $40.80M |
Free Cash Flow OCF − CapEx | $-420.00M | $-832.50M | $-710.70M | $-793.70M |
Shares Outstanding | 478.43M | 469.82M | 447.38M | 412.14M |